This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. At the same time, MSLs are being asked to help inform brand strategy with their learnings from talking to leading healthcare professionals.
“NEJM is pleased to participate in an innovative new service from CCC that aligns with our goal to meet the information needs of researchers for the highest quality studies in medicalscience,” said Rob McKinney, Director, NEJM Group Licensing. NEJM is recognized as the world’s leadingmedical journal and website.
The primary purpose of MedicalScience Liaison MSL is to establish and maintain peer-peer relationships with leadingphysicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. Asking strategic questions leads to a better understanding of medical practices and habits.
While medicalscience advances, too many clinics still rely on cumbersome paperwork. Improve Data Accuracy and Compliance Handwritten forms can lead to misinterpretations, incomplete fields, and errors impacting patient care and compliance with healthcare regulations. Whats the solution to such an age-old problem?
Embracing these vital aspects of learning leads to performance improvement. Medicalscience is making huge strides; with the landscape fracturing and reforming through and after COVID, there is an imperative to put these advances into practice. Continuing education as a contributor to mitigating physician burnout.
Thanks to kind support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below), we met with Ronan Castro, the CEO of Human Xtensions at the company’s offices in Netanya, Israel. are still done in an open fashion.
It will also be important for referring physicians like myself, to begin thinking about referrals earlier than they may have traditionally done so in the past. About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Medical Affairs.
These advancements will ensure that future healthcare professionals are well-equipped to deliver the best possible care to patients, navigating the intricacies of medicalscience with a blend of knowledge and practical ability.
I think that it’s very important for biosimilars that health plans allow physicians to prescribe the biosimilar, or at least provide an option of a biosimilar as that first-line treatment, Chambers said. So, that’s quite the hurdle for access, I think. Regional Account Manager, and Shaun Terry, Sr.
This leads to substantial damage to healthy tissues and too often results in poor outcomes. To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources.
Last year, lifileucel was previously plagued by a different delay, which was an inability to convince the US Food and Drug Administration (FDA) that its potency assays for TILs were robust enough to lead to a uniform product. Only 29% of patients successfully received the CAR-T product within 12 months, and 31.9%
Pharmaceutical sales representatives (often times referred to as pharma reps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product. What skills are necessary to become a pharma sales rep?
He provides a fascinating glimpse into what it takes to excel in the field of medical device sales, emphasizing the importance of authenticity and passion. The perfect blend of persistent dedication, a heartwarming touch of southern hospitality, and an innate understanding of the needs of both physicians and patients. I find Dr. B.
Customer conversion and product uptake have largely depended upon live interactions between treating physicians and biopharma representatives (e.g., sales, medicalscience liaisons, etc.). Which physicians see these patients? Beyond age and pre-existing medical conditions, what other characteristics put patients at risk?
Medicalscience Liaisons know that change is coming; How are they cashing in? Medicalscience liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.
The definition of an “insight” is inconsistent as per the medical affairs function. A medical insight can take many forms, including sentiment, individual perceptions, data points, and trends within healthcare.
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medicalscience liaisons (MSLs) through virtual communications. We have identified five steps to delivering more engaging customer experiences with HCPs and patients.
Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. This offers new opportunities to engage with stakeholders beyond just physicians. Evolution of the MSL Function Earlier this year, Peter J.
But educating the world of physicians about these new medicines and collaborating with healthcare professionals on trials and other important initiatives is critical to their commercial success. With this comes new hope for previously underserved patient populations. A fresh approach.
MedicalSpecialty Any specific branch of medicalscience or practice, including clinical specialties about organ systems and their respective diseases and allied health specialties. Physician An individual physician or a physician’s office considered as a “MedicalOrganization.”
It’s one of those interviews that can stick with you and inspire you as you continue to go on and lead the wonderful career you are trying to lead. As always, we do our best to bring you guests who are doing things differently in the medical sales space and I do hope you enjoy this episode. I was inspired by it.
In order to achieve these goals, the medical representative arranges meetings with doctors, nurses, pharmacists, and nutritionists and gives presentations on medicines and medical equipment. It is relatively difficult to sell medical products and convert leads to sales, especially in the early stages of developing a new product.
National Sales Director: Lead strategy for the entire sales division, and manage teams across regions. Medical Education Specialist: Create CME/CE-accredited training on medical products for physicians. Marketing Manager: Oversee marketing activities including campaigns, materials, and digital efforts.
Hait , Executive VP, Chief External Innovation and Chief Medical Officer, Johnson & Johnson , a renowned physician-scientist and Treasurer of the American Association for Cancer Research engaged in a thought-provoking discussion on the evolving landscape of cancer research and treatment. Dr. William N.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content